A population-based study of intensive care unit admissions in rheumatoid arthritis

Journal of Rheumatology

Volumn 43, Issue 1, 2016, Pages 26-33

  Peschken, Christine A ^a   Hitchon, Carol A ^a   Garland, Allan ^b   Bernstein, Charles N ^a   Chen, Hui ^b   Fransoo, Randy ^b   Marrie, Ruth Ann ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Administrative data; Critical illness; Incidence; Rheumatoid arthritis

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL DATA REPOSITORY; CONTROLLED STUDY; CRITICAL ILLNESS; DEMOGRAPHY; FEMALE; HEALTH CARE POLICY; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POPULATION RESEARCH; PREVALENCE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SEX DIFFERENCE; SOCIAL STATUS; AGED; ARTHRITIS, RHEUMATOID; CASE CONTROL STUDY; CAUSE OF DEATH; COMPARATIVE STUDY; FACTUAL DATABASE; HOSPITAL MORTALITY; KAPLAN MEIER METHOD; MANITOBA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; REFERENCE VALUE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; TRENDS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CAUSE OF DEATH; CRITICAL ILLNESS; DATABASES, FACTUAL; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; KAPLAN-MEIER ESTIMATE; MALE; MANITOBA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT ADMISSION; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 85011796883     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.150312     Document Type: Article

References (49)

1. Health Canada. Arthritis in Canada: an ongoing challenge. [Internet. Accessed October 26, 2015.] Available from: www.acreu.ca/pdf/Arthritis-in-Canada.pdf
2. Gullick NJ, Scott DL. Co-morbidities in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2011;25:469-83.
3. Myasoedova E, Crowson CS, Nicola PJ, Maradit-Kremers H, Davis JM 3rd, Roger VL, et al. The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol 2011;38:1601-6.
4. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008;26 Suppl 51:S35-61.
5. Kalkan A, Hallert E, Bernfort L, Husberg M, Carlsson P. Costs of rheumatoid arthritis during the period 1990-2010: a register-based cost-of-illness study in Sweden. Rheumatology 2014;53:153-60.
6. Ohinmaa AE, Thanh NX, Barnabe C, Martin L, Russell AS, Barr SG, et al. Canadian estimates of health care utilization costs for rheumatoid arthritis patients with and without therapy with biologic agents. Arthritis Care Res 2014;66:1319-27.
7. da Rocha Castelar Pinheiro G, Khandker RK, Sato R, Rose A, Piercy J. Impact of rheumatoid arthritis on quality of life, work productivity and resource utilisation: an observational, cross-sectional study in Brazil. Clin Exp Rheumatol 2013;31:334-40.
8. Michaud K, Messer J, Choi HK, Wolfe F. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients. Arthritis Rheum 2003;48:2750-62.
9. Boonen A, Severens JL. The burden of illness of rheumatoid arthritis. Clin Rheumatol 2011;30 Suppl 1:S3-8.
10. Wright K, Crowson CS, Gabriel SE. Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure. Heart Fail Clin 2014;10:339-52.
11. Wolfe F, Michaud K. The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis. Arthritis Rheum 2008;58:2612-21.
12. Troelsen LN, Garred P, Jacobsen S. Mortality and predictors of mortality in rheumatoid arthritis - a role for mannose-binding lectin? J Rheumatol 2010;37:536-43.
13. Koivuniemi R, Paimela L, Leirisalo-Repo M. Causes of death in patients with rheumatoid arthritis from 1971 to 1991 with special reference to autopsy. Clin Rheumatol 2009;28:1443-7.
14. Resman-Targoff BH, Cicero MP. Aggressive treatment of early rheumatoid arthritis: recognizing the window of opportunity and treating to target goals. Am J Manag Care 2010;16 Suppl:S249-58.
15. Dixon WG, Suissa S, Hudson M. The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses. Arthritis Res Ther 2011;13:R139.
16. Furst DE. The risk of infections with biologic therapies for rheumatoid arthritis. Semin Arthritis Rheum 2010;39:327-46.
17. Ruyssen-Witrand A, Fautrel B, Saraux A, Le-Loët X, Pham T. Infections induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review. Joint Bone Spine 2010;77:246-51.
18. Listing J, Gerhold K, Zink A. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology 2013;52:53-61.
19. Sizova L. Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs. Br J Clin Pharmacol 2008;66:173-8.
20. Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Ustianowski AP, Helbert M, et al; BSR Biologics Register. Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2011;70:1810-4.
21. Greenberg JD, Reed G, Kremer JM, Tindall E, Kavanaugh A, Zheng C, et al; CORRONA Investigators. Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. Ann Rheum Dis 2010;69:380-6.
22. Dedhia H, DiBartolomeo A. Rheumatoid arthritis. Crit Care Clin 2002;18:841-54.
23. Janssen NM, Karnad DR, Guntupalli KK. Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome. Crit Care Clin 2002;18:729-48.
24. Godeau B, Boudjadja A, Dhainaut JF, Schlemmer B, Chastang C, Brunet F, et al. Outcome of patients with systemic rheumatic disease admitted to medical intensive care units. Ann Rheum Dis 1992;51:627-31.
25. Ozbalkan Z, Topeli A, Kiraz S, Ozturk MA, Ertenli I, Calguneri M. The contribution of underlying systemic rheumatic diseases to the mortality in patients admitted for intensive care: a matched cohort study. Clin Exp Rheumatol 2004;22:223-6.
26. Thong BY, Tai DY, Goh SK, Johan A. An audit of patients with rheumatic disease requiring medical intensive care. Ann Acad Med Singapore 2001;30:254-9.
27. Health Information Management Branch. Population report. Winnipeg: Manitoba Health and Healthy Living; 2009.
28. Haupt MT, Bekes CE, Brilli RJ, Carl LC, Gray AW, Jastremski MS, et al; Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Guidelines on critical care services and personnel: recommendations based on a system of categorization of three levels of care. Crit Care Med 2003;31:2677-83.
29. Garland A, Fransoo R, Olafson K, Ramsey C, Yogendran M, Chateau D, et al. The Epidemiology and outcomes of critical illness in Manitoba. [Internet. Accessed October 26, 2015.] Available from: mchp-appserv.cpe.umanitoba.ca/reference/MCHP-ICU-Report-WEB-(20120403).pdf
30. Garland A, Yogendran M, Olafson K, Scales DC, McGowan KL, Fransoo R. The accuracy of administrative data for identifying the presence and timing of admission to intensive care units in a Canadian province. Med Care 2012;50:e1-6.
31. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100:1619-36.
32. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2:81-4.
33. Peschken C, Hitchon C, Chen H, Garland A, El-Gabalawy H, Bernstein C, et al. Administrative definitions of rheumatoid arthritis: rising prevalence regardless of definition used. Arthritis Rheum 2011;63:S1009.
34. Sun J, Gooch K, Svenson LW, Bell NR, Frank C. Estimating osteoarthritis incidence from population-based administrative health care databases. Ann Epidemiol 2007;17:51-6.
35. Marrie RA, Bernstein CN, Peschken CA, Hitchon CA, Chen H, Fransoo R, et al. Intensive care unit admission in multiple sclerosis: increased incidence and increased mortality. Neurology 2014;82:2112-9.
36. Marrie RA, Garland A, Peschken CA, Hitchon CA, Chen H, Fransoo R, et al. Increased incidence of critical illness among patients with inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol 2014;12:2063-70.
37. Needham DM, Scales DC, Laupacis A, Pronovost PJ. A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care 2005;20:12-9.
38. Preen DB, Holman CD, Spilsbury K, Semmens JB, Brameld KJ. Length of comorbidity lookback period affected regression model performance of administrative health data. J Clin Epidemiol 2006;59:940-6.
39. Camargo JF, Tobon GJ, Fonseca N, Diaz JL, Uribe M, Molina F, et al. Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature. Lupus 2005;14:315-20.
40. Wasko MC. Comorbid conditions in patients with rheumatic diseases: an update. Curr Opin Rheumatol 2004;16:109-13.
41. Kremers HM, Crowson CS, Therneau TM, Roger VL, Gabriel SE. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum 2008;58:2268-74.
42. Young A, Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:907-27.
43. Symmons DP, Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 2011;7:399-408.
44. Symmons D, Turner G, Webb R, Asten P, Barrett E, Lunt M, et al. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology 2002;41:793-800.
45. Anderson ST. Mortality in rheumatoid arthritis: do age and gender make a difference? Semin Arthritis Rheum 1996;25:291-6.
46. Minaur NJ, Jacoby RK, Cosh JA, Taylor G, Rasker JJ. Outcome after 40 years with rheumatoid arthritis: a prospective study of function, disease activity, and mortality. J Rheumatology Suppl 2004 Mar;69:3-8.
47. Verstappen SM, Symmons DP. What is the outcome of RA in 2011 and can we predict it? Best Pract Res Clin Rheumatol 2011;25:485-96.
48. Hoovestol RA, Mikuls TR. Environmental exposures and rheumatoid arthritis risk. Curr Rheumatol Rep 2011;13:431-9.
49. Klareskog L, Malmström V, Lundberg K, Padyukov L, Alfredsson L. Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol 2011;23:92-8.